Cimetidine vs famotidine efficacy
Pro Research Analysisby 
Searched over 200M research papers
Duodenal Ulcer Healing: Famotidine vs Cimetidine Efficacy
Multiple clinical trials have compared famotidine and cimetidine for treating active and acute duodenal ulcers. Both drugs are effective, with similar rates of ulcer healing and pain relief. However, some studies show a trend toward higher healing rates with famotidine. For example, after 4 weeks, 91.6% of patients on famotidine had healed ulcers compared to 82.3% on cimetidine, and after 6 weeks, the rates were 96% for famotidine and 85.1% for cimetidine, though this difference was not statistically significant (p = 0.056) . Another study found healing rates at 4 weeks were 95% for famotidine and 85% for cimetidine, with no significant difference in pain relief or antacid use . Overall, both drugs are effective, but famotidine may offer a slight advantage in healing rates.
Gastric Acid Suppression and pH Control
Famotidine is more potent than cimetidine in raising intragastric pH, even at lower doses. In healthy volunteers, a single 10 mg dose of famotidine increased gastric pH more significantly and for a longer duration than 100 mg or 200 mg of cimetidine, with pH above 3 for a greater percentage of the night . In postoperative patients, famotidine provided better gastric pH control than cimetidine, which is important for preventing stress ulcers . Famotidine’s longer duration of action and higher potency make it more effective for acid suppression 58.
Safety and Side Effects: Famotidine vs Cimetidine
Both famotidine and cimetidine have similar overall safety profiles in clinical use, with comparable rates of adverse effects 125. However, cimetidine is more likely to cause certain side effects, such as antiandrogenic effects and drug interactions due to inhibition of hepatic metabolism. Famotidine does not significantly inhibit hepatic drug metabolism, making it less likely to interact with other medications 59. In critically ill patients, cimetidine can cause a significant drop in blood pressure, while famotidine has little effect on hemodynamics, making it safer for patients requiring vasoconstrictor support .
Special Clinical Situations
For patients with gastric hypersecretory states, such as Zollinger-Ellison syndrome, famotidine is much more potent than cimetidine and has a longer duration of action, allowing for less frequent dosing and better control of acid secretion . In the context of surgery, both drugs reduce gastric volume and acidity, but famotidine may be more reliable in preventing very low gastric pH and high secretion volumes, which are risk factors for Mendelson’s syndrome .
Other Considerations: Radioprotection
In animal studies, cimetidine was found to be more protective than famotidine against radiation-induced mortality, possibly due to immunomodulatory effects. However, this finding is specific to radioprotection and not directly related to acid suppression or ulcer healing in humans .
Conclusion
Both famotidine and cimetidine are effective for treating duodenal ulcers and controlling gastric acid. Famotidine is generally more potent, provides better acid suppression, and has a longer duration of action. It is also less likely to cause drug interactions or hemodynamic instability, making it preferable in many clinical situations. Cimetidine may have unique benefits in radioprotection, but for most acid-related disorders, famotidine offers advantages in efficacy and safety 1245+4 MORE.
Sources and full results
Most relevant research papers on this topic